TOP2A and breast cancer: Unlike CCNB1, CCNA2, and CDK1, currently, the remaining genes (TOP2A, KIF11, and MELK) are not found to be associated with cell cycle; their dysfunctions might still affect the progression and prognosis of breast cancer.